Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 25, 2017
Pharmacy Choice - News - Generic Drugs - May 25, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 48     Next >>     Go To Page:

5/25/17 - Eatontown drug execs will tell all in price-fixing case [Asbury Park Press, N.J.]
May 24 Two former drug company executives from Monmouth County reached a settlement and will cooperate with investigators in a price-fixing case against some of the nation's biggest generic drug makers, authorities said Wednesday. Jeffery Glazer and Jason Malek, who led Heritage Pharmaceuticals in Eatontown, agreed to provide documents, testimony
5/25/17 - Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR by Par Pharmaceutical [Tehran Times (Iran)]
-Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its United States marketing partner, Par Pharmaceutical Inc., has launched the 10 and 20 mg strengthsof its generic...
5/25/17 - Julphar's Board of Directors Meeting Held on May 18th, 2017 [Mid-East.Info]
By 2020, the Emirati company aims to reach more than AED 2 billion sales and rank among the top 3 pharmaceutical companies in the UAE and in Saudi Arabia. Despite challenging market conditions and the overall regional situation that are impacting our industry, Julphar is consolidating its market share for the first Quarter, said Jerome Carle,
5/25/17 - Orchid Pharma gets US FDA approval for Aripiprazole tablet [Sudan Tribune]
Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application approval from US FDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. Orchid Pharma Limited was trading at Rs 30.25, up by Rs 0.60 or 2.02%, on Wednesday, on the BSE. Orchid Pharma Ltd is currently trading
5/25/17 - States Have Reached Settlements, Cooperation Agreements With Two Former Drug Company Executives
New Jersey Attorney General Christopher S. Porrino issued the following news release:. Two former executives of a New Jersey- based generic pharmaceutical manufacturing company have entered into settlement and cooperation agreements with 41 states including New Jersey that are investigating what they allege is widespread anti-competitive activi
5/25/17 - Virginia, 40 Other States Reach Settlements, Cooperation Agreements with Two Former Executives in Generic Drug Multistate Investigation
Attorney General Mark R. Herring announced today that two former executives of a New Jersey- based generic pharmaceutical manufacturer have entered into settlement and cooperation agreements with 40 states that are investigating what they allege is widespread anticompetitive activity in the generic drug industry that has led to higher prices for...
5/24/17 - Dramatic increase in patient access across Europe [Sudan Tribune]
Medicines for Europe acknowledges the role of the European Commission and its partnership with QuintilesIMS in pursuing the dialogue and close monitoring of the unfolding competition in the biologics market. The new report on The Impact of Biosimilar Competition in Europe highlights the visible benefits of biosimilar competition to increase patient
5/24/17 - Findings from Pfizer Reveals New Findings on Follicular Lymphoma (Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the...
By a News Reporter-Staff News Editor at Biotech Week New research on Oncology- Follicular Lymphoma is the subject of a report. According to news reporting from New York City, New York, by NewsRx journalists, research stated, "Follicular lymphoma is the second most common type of non-Hodgkin's lymphoma. The news correspondents obtained a quote fro
5/24/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 18298) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Oncologic Drugs Advisory Committee to discuss biologics license application 125545, for a proposed biosimilar to Amgen Inc.' s Epogen/Procrit, submitted by Hospira Inc., a Pfizer company, for the treatment of anemia. LOCATION: FDA White Oak Campus, 1090
5/24/17 - Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR by Par Pharmaceutical
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its United States marketing partner, Par Pharmaceutical Inc., has launched the 10 and 20 mg strengths of its generic.
5/24/17 - Orchid Pharma gets US FDA approval for Aripiprazole tablet [India Infoline News Service]
Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application approval from US FDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application approval from US
5/24/17 - Report Summarizes Antineoplastic Monoclonal Antibodies Study Findings from Amgen (A randomized, single-blind, single-dose study evaluating the...
By a News Reporter-Staff News Editor at Biotech Week Researchers detail new data in Drugs and Therapies- Antineoplastic Monoclonal Antibodies. According to news reporting originating in Thousand Oaks, California, by NewsRx journalists, research stated, "This study compared the pharmacokinetic profiles of the proposed biosimilar ABP 980 and trastu
5/24/17 - Research Results from University Hospital Ulm Update Knowledge of Biologics (An introduction to biosimilar cancer therapeutics: definitions,...
By a News Reporter-Staff News Editor at Biotech Week New research on Biotechnology- Biologics is the subject of a report. According to news reporting originating from Ulm, Germany, by NewsRx correspondents, research stated, "Monoclonal antibodies and other biologic drugs play important roles in the treatment of various hematological malignancies
5/24/17 - Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
The FDA filing acceptance follows acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency in March 2017. The acceptance of the regulatory filing by the U.S. FDA marks a significant milestone as we seek to advance for tildrakizumab as a potential new treatment option for people who continue to struggle everyday with the
5/23/17 - Biosimilar medicines: Dramatic increase in patient access across Europe
Biosimilar medicines have dramatically increased patient access to biological medicines, according to the recently published QuintilesIMS report...
5/23/17 - Biosimilars Market is expected to reach USD 10.90 billion by 2021
Biosimilars Market by Product, Manufacturing& Application- Global Forecast To 2021. The global biosimilars market is expected to reach USD 10.90 billion by 2021 from USD 3.39 billion in 2016, at a CAGR of 26.3%. The biosimilars market is broadly classified into product, manufacturing type, application, and region. On the basis of product, the biosi
5/23/17 - Miraca Life Sciences Again Expands Therapeutic Drug Monitoring with Addition of First Biosimilar Inflectra
Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, has further expanded its InformTx? therapeutic drug monitoring capabilities with the addition of testing for Inflectra , which is the first biosimilar drug in the test offering. Since launching InformTx in June 2016, Miraca Life Sciences has expanded the service f
5/23/17 - New Oncology Findings from Tokai Central Hospital Discussed (Scientific rationale for extrapolation of biosimilar data across cancer indications:...
By a News Reporter-Staff News Editor at Cancer Weekly Data detailed on Oncology have been presented. According to news reporting originating in Gifu, Japan, by NewsRx journalists, research stated, "For a biosimilar to gain regulatory approval, a comprehensive comparability exercise must demonstrate that it is highly similar to its originator biol
5/23/17 - Rep. Kelly Introduces Bipartisan Bill to Reduce Prescription Drug Prices
WASHINGTON U.S. Representative Mike Kelly- a member of the House Ways and Means Committee- released the following statement today after introducing H.R. 2562, the Making Pharmaceutical Markets More Competitive Act, in the House of Representatives. The legislation requires the Food and Drug Administration to prioritize the review of generic drug..
5/22/17 - Biosimilars Insulin Market Foreseen to Grow Exponentially over 2016 2024 : Persistence Market Research
This created a necessity to seek approvals on biosimilar insulin for the not yet established companies in the highly regulated markets such as Europe and United States. In 2014, The European Commission first granted insulin treatment through the biosimilars pathway to Eli Lilly and Company and Boehringer Ingelheim GmbH. Lilly/Boehringer Ingelheim..
5/22/17 - Blog Coverage: CHMP Okays French Pharma Major Sanofi's Insulin Lispro Biosimilar for Treatment of Diabetes Mellitus
LONDON, UK/ ACCESSWIRE/ May 22, 2017/ Active Wall St. blog coverage looks at the headline from Sanofi as the Company announced on May 19, 2017, that the Committee for Medicinal Products for Human Use of the European Medicines Agency had adopted a positive opinion for the marketing authorization of Insulin lispro Sanofi . One of Sanofi's competito
5/22/17 - Elite Pharmaceuticals Acquires Trimipramine ANDA
Elite Pharmaceuticals, Inc., today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application for Trimipramine Maleate Capsules 25, 50 and 100 mg, from Mikah Pharma, LLC. Reddy s Laboratories, Inc.,, will market and sell the Trimipramine products. Elite Pharmaceuticals, Inc. is a specialty pharmaceutical c
5/22/17 - FUJIFILM KYOWA KIRIN BIOLOGICS Announces Marketing Authorisation Application for FKB327 Accepted for Review by European Medicines Agency
FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. announces that on May 18, 2017, the European Medicines Agency has accepted for review the Marketing Authorisation Application for FKB327, an adalimumab biosimilar candidate to the fully human anti-TNF-* 1 monoclonal antibody, Humira . In December 2014, Fujifilm Kyowa Kirin Biologics began a Phase 3 globa
5/22/17 - Granules India to expand pharmaceutical operation in Fairfax
Granules India Ltd. is planning to invest $35 million to expand its pharmaceutical research and development and manufacturing operation in Fairfax County. Granules India is headquartered in Hyderabad, India. "Granules Pharmaceuticals Inc. will focus on developing complex generic products by leveraging in-house technology that will increase...
5/22/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 18298) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Oncologic Drugs Advisory Committee to discuss biologics license application 125545, for a proposed biosimilar to Amgen Inc.' s Epogen/Procrit, submitted by Hospira Inc., a Pfizer company, for the treatment of anemia. LOCATION: FDA White Oak Campus, 1090
Articles(s): 1 - 25 of 48     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415